PDA Announces the Volunteer Members of its 2023 Board of Directors and Officers

News provided by

PDA

Dec 14, 2022, 13:00 ET


PDA members selected four new board members during the 2022 election.

BETHESDA, Md., Dec. 14, 2022 /PRNewswire-PRWeb/ -- The Parenteral Drug Association (PDA) today announced the volunteer members of its 2023, which will be the most geographically diverse in PDA's history.

Newly elected Directors are:

  • Christiana Campa, PhD, GSK (Italy)
  • Cylia Chen Ooi, Amgen (United States)
  • Marc Gloglovsky, ValSource Inc. (United States)
  • Ivy Louis, VIENNI Taining & Consulting LLP (India)

Mathias Romacker's term of service as a director was also extended for 2023.

"The incoming members of the 2023 Board of Directors reflects the growing diversity of PDA's global membership," said Richard Johnson, PDA President & CEO. "On behalf of PDA, I would like to congratulate these candidates, and all the qualified members who ran in the 2022 board election."

The complete 2022-2023 Board of Directors and Officers will be composed of the following volunteers:
Officers

  • Chairs:     Sue Schniepp, Regulatory Compliance Associates Inc.
  • Chair-Elect: Anil Sawant, Merck & Co./Merck, Sharp & Dohme
  • Treasurer: Melissa Seymour, Biogen, Inc.
  • Secretary: Emma Ramnarine, Genentech/Roche
  • Imm. Past Chair:    Jette Christensen, Novo Nordisk

Directors

  • Bettine Boltres, West Pharmaceutical Services
  • Christiana Campa, PhD, GSK
  • Javier Camposano, Celltrion
  • Mirko Gabriele, Thermo Fisher Scientific
  • Marc Gloglovsky, ValSource Inc.
  • Andrew Hopkins, Abbvie
  • Stephan Krause, AstraZeneca Biologics
  • Ivy Louis, VIENNI Taining & Consulting LLP
  • Amy McDaniel, Bristol Myers Squibb
  • Cylia Chen Ooi, Amgen
  • Mathias Romacker (ret.)
  • Osamu Shirokizawa, Lifescientia

About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its 10,000 members worldwide. Go to http://www.pda.org/footer/about-pda to learn more.
###

Media Contact

Walter Morris, www.pda.org, 1 3016565900, [email protected]

SOURCE PDA